These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3838817

  • 1. Inhibition of renal membrane binding and nephrotoxicity of gentamicin by polyasparagine and polyaspartic acid in the rat.
    Williams PD, Hottendorf GH.
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):317-20. PubMed ID: 3838817
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat.
    Ramsammy LS, Josepovitz C, Lane BP, Kaloyanides GJ.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):149-53. PubMed ID: 2746494
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of renal Na+, K+-adenosine triphosphatase by gentamicin.
    Williams PD, Trimble ME, Crespo L, Holohan PD, Freedman JC, Ross CR.
    J Pharmacol Exp Ther; 1984 Nov; 231(2):248-53. PubMed ID: 6092609
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity.
    Gilbert DN, Wood CA, Kohlhepp SJ, Kohnen PW, Houghton DC, Finkbeiner HC, Lindsley J, Bennett WM.
    J Infect Dis; 1989 May; 159(5):945-53. PubMed ID: 2651534
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Renal brush border membrane vesicle aminoglycoside binding and nephrotoxicity.
    Todd JH, Hottendorf GH.
    J Pharmacol Exp Ther; 1995 Jul; 274(1):258-63. PubMed ID: 7616406
    [Abstract] [Full Text] [Related]

  • 15. [Can gentamicin nephrotoxicity in rats be modified by chronic administration of muzolimine?].
    Toutain H, Olier B, Fillastre JP, Morin JP.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):582-6. PubMed ID: 3534747
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
    Kishore BK, Lambricht P, Laurent G, Maldague P, Wagner R, Tulkens PM.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Poly-L-aspartic acid does but triiodothyronine does not protect against gentamicin-induced cytotoxicity in the porcine kidney cell line LLC-PK1.
    Whittem T, Schnellmann RG, Ferguson DC.
    J Pharmacol Exp Ther; 1992 Aug; 262(2):834-40. PubMed ID: 1354256
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.